Clinical trialNCT00853762TerminatedPhase 2Interventional

Atacicept in Multiple Sclerosis Extension Study, Phase II

SponsorEMD SeronoEnrollment74Relapsing Multiple Sclerosis

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Daniel Mikol, MD, PhD
EMD Serono
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Research Site
Box Hill VIC, Australia
Research Site
Fitzroy, Australia
Research Site
New Lambton, Australia
Research Site
Woodville, Australia

Belgium

Research Site
Diepenbeek, Belgium
Research Site
Sijsele, Belgium

Canada

Research Site
Calgary, Alberta, Canada
Research Site
Ottawa, Ontario, Canada

Czechia

Research Site
Brno, Czechia
Research Site
Hradec Králové, Czechia

France

Research Site
Caen, France
Research Site
Saint-Herblain, France

Germany

Research Site
Bochum, Germany
Research Site
Düsseldorf, Germany

Lebanon

Research Site
Beirut, Lebanon

Lithuania

Research Site
Kaunas, Lithuania

Netherlands

Research Site
Breda, Netherlands
Research Site
Nieuwegein, Netherlands
Research Site
Rotterdam, Netherlands

New Caledonia

Research Site
Winston Salem, New Caledonia

Russia

Research Site
Moscow, Russia
Research Site
Novosibirsk, Russia
Research Site
Saint Petersburg, Russia
Research Site
Samara, Russia
Research Site
Vladimir, Russia
Research Site
Yaroslavl, Russia
Research Site
Yekaterinburg, Russia

Spain

Research Site
Barcelona, Spain
Research Site
Madrid, Spain
Research Site
Málaga, Spain

Sweden

Research Site
Stockholm, Sweden

Switzerland

Research Site
Basel, Switzerland
Research Site
Innsbruck, Switzerland
Research Site
Zurich, Switzerland

Ukraine

Research Site
Kharkiv, Ukraine
Research Site
Kyiv, Ukraine
Research Site
Odesa, Ukraine
Research Site
Uzhhorod, Ukraine

United Kingdom

Research Site
London, United Kingdom
Research Site
Sheffield, United Kingdom

7 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2009
Primary completion: 30 Sept 2009
Completion: 28 Feb 2011
Last update posted: 20 Mar 2017
Registered enrollment: 74
Registry id: NCT00853762

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.